|
US6602864B1
(en)
*
|
1996-12-13 |
2003-08-05 |
Aventis Pharma Deutschland Gmbh |
Sulfonic acid or sulfonylamino N-(heteroaralkyl)-azaheterocyclylamide compounds
|
|
WO1999011658A1
(en)
*
|
1997-08-29 |
1999-03-11 |
Proteus Molecular Design Ltd. |
Meta-benzamidine derivatives as serin protease inhibitors
|
|
AU753675B2
(en)
|
1998-03-19 |
2002-10-24 |
Ajinomoto Co., Inc. |
Aminoisoquinoline derivatives
|
|
EP1104754A1
(en)
*
|
1998-08-11 |
2001-06-06 |
Daiichi Pharmaceutical Co., Ltd. |
Novel sulfonyl derivatives
|
|
DE69912379T2
(de)
*
|
1998-08-14 |
2004-05-06 |
Pfizer Inc. |
Antithrombosemittel
|
|
TW575567B
(en)
*
|
1998-10-23 |
2004-02-11 |
Akzo Nobel Nv |
Serine protease inhibitor
|
|
WO2000038683A1
(en)
*
|
1998-12-23 |
2000-07-06 |
Du Pont Pharmaceuticals Company |
THROMBIN OR FACTOR Xa INHIBITORS
|
|
KR20000047461A
(ko)
*
|
1998-12-29 |
2000-07-25 |
성재갑 |
트롬빈 억제제
|
|
US7015230B1
(en)
|
1999-05-19 |
2006-03-21 |
Pharmacia Corporation |
Substituted polycyclic aryl and heteroaryl uracils useful for selective inhibition of the coagulation cascade
|
|
KR20010113970A
(ko)
*
|
1999-05-19 |
2001-12-28 |
추후보정 |
응고 캐스케이드의 선택적 억제에 유용한 치환 폴리시클릭아릴 및 헤테로아릴 피리돈
|
|
US6750342B1
(en)
|
1999-05-19 |
2004-06-15 |
Pharmacia Corporation |
Substituted polycyclic aryl and heteroaryl pyrimidinones useful for selective inhibition of the coagulation cascade
|
|
US6867217B1
(en)
|
1999-05-19 |
2005-03-15 |
Pharmacia Corporation |
Substituted polycyclic aryl and heteroaryl pyridones useful for selective inhibition of the coagulation cascade
|
|
US6653316B1
(en)
|
1999-05-19 |
2003-11-25 |
Pharmacia Corporation |
Substituted polycyclic aryl and heteroaryl pyrimidinones useful for selective inhibition of the coagulation cascade
|
|
US6716838B1
(en)
|
1999-05-19 |
2004-04-06 |
Pharmacia Corporation |
Substituted polycyclic aryl and heteroaryl uracils as anticoagulative agents
|
|
US6458952B1
(en)
|
1999-05-19 |
2002-10-01 |
Pharmacia Corporation |
Substituted polycyclic aryl and heteroaryl uracils useful for selective inhibition of the coagulation cascade
|
|
US6664255B1
(en)
|
1999-05-19 |
2003-12-16 |
Pharmacia Corporation |
Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade
|
|
US6545055B1
(en)
*
|
1999-05-24 |
2003-04-08 |
Millennium Pharmaceuticals, Inc. |
Inhibitors of factor Xa
|
|
CA2383008A1
(en)
*
|
1999-06-14 |
2000-12-21 |
Amanda Jane Lyons |
Compounds
|
|
CA2375920A1
(en)
*
|
1999-06-14 |
2000-12-21 |
Eli Lilly And Company |
Compounds
|
|
GB9929552D0
(en)
*
|
1999-12-14 |
2000-02-09 |
Proteus Molecular Design |
Compounds
|
|
DE60018213T2
(de)
*
|
1999-12-27 |
2005-12-29 |
Ortho-Mcneil Pharmaceutical, Inc. |
Substituierte aminoalkylamid-derivate als antagonisten des follikel-stimulierenden hormons
|
|
WO2001068605A1
(en)
|
2000-03-13 |
2001-09-20 |
Pharmacia Corporation |
Polycyclic aryl and heteroaryl substituted benzenes useful for selective inhibition of the coagulation cascade
|
|
EP1267876A1
(en)
*
|
2000-03-23 |
2003-01-02 |
Merck & Co., Inc. |
Thrombin inhibitors
|
|
ATE289299T1
(de)
|
2000-04-05 |
2005-03-15 |
Pharmacia Corp |
Polyzyclisch aryl und heteroaryl substituierte 4- pyronen verwendbar als selektive hemmung von dem koagulationsprozess
|
|
AU2001251315A1
(en)
|
2000-04-05 |
2001-10-23 |
Pharmacia Corporation |
Polycyclic aryl and heteroaryl substituted 4-pyridones useful for selective inhibition of the coagulation cascade
|
|
EP1274676A2
(en)
|
2000-04-17 |
2003-01-15 |
Pharmacia Corporation |
Polycyclic aryl and heteroaryl substituted 1,4-quinones useful for selective inhibition of the coagulation cascade
|
|
SI20582A
(sl)
|
2000-05-05 |
2001-12-31 |
Univerza V Ljubljani |
Novi inhibitorji trombina, njihova priprava in uporaba
|
|
EP1283199A4
(en)
*
|
2000-05-16 |
2003-12-17 |
Takeda Chemical Industries Ltd |
MELANINE CONCENTRATING HORMONE ANTAGONISTS
|
|
WO2001087851A1
(en)
*
|
2000-05-18 |
2001-11-22 |
Pharmacia Corporation |
Substituted polycyclic aryl and heteroaryl pyrimidinones useful for selective inhibition of the coagulation cascade
|
|
GB0030304D0
(en)
|
2000-12-13 |
2001-01-24 |
Lilly Co Eli |
Compounds
|
|
GB0030303D0
(en)
|
2000-12-13 |
2001-01-24 |
Lilly Co Eli |
Compounds
|
|
GB0030306D0
(en)
|
2000-12-13 |
2001-01-24 |
Lilly Co Eli |
Compounds
|
|
GB0030305D0
(en)
|
2000-12-13 |
2001-01-24 |
Lilly Co Eli |
Compounds
|
|
US7074934B2
(en)
|
2000-06-13 |
2006-07-11 |
Tularik Limited |
Serine protease inhibitors
|
|
SK322003A3
(en)
|
2000-07-12 |
2003-06-03 |
Akzo Nobel Nv |
Thrombin inhibitors comprising an aminoisoquinoline group
|
|
EP1332131A2
(en)
|
2000-11-07 |
2003-08-06 |
Bristol-Myers Squibb Company |
Acid derivatives useful as serine protease inhibitors
|
|
US6906192B2
(en)
|
2000-11-07 |
2005-06-14 |
Bristol Myers Squibb Company |
Processes for the preparation of acid derivatives useful as serine protease inhibitors
|
|
US7015223B1
(en)
|
2000-11-20 |
2006-03-21 |
Pharmacia Corporation |
Substituted polycyclic aryl and heteroaryl 1,2,4-triazinones useful for selective inhibition of the coagulation cascade
|
|
CA2430037A1
(en)
|
2000-11-20 |
2002-05-30 |
Michael S. South |
Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade
|
|
US7119094B1
(en)
|
2000-11-20 |
2006-10-10 |
Warner-Lambert Company |
Substituted polycyclic aryl and heteroarpyl pyrazinones useful for selective inhibition of the coagulation cascade
|
|
GB0114185D0
(en)
|
2001-06-12 |
2001-08-01 |
Protherics Molecular Design Lt |
Compounds
|
|
HUP0304058A2
(hu)
|
2001-01-30 |
2004-04-28 |
Bristol-Myers Squibb Company |
Xa faktor szulfonamid-laktám inhibitorok és alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények
|
|
GB0114005D0
(en)
|
2001-06-08 |
2001-08-01 |
Glaxo Group Ltd |
Chemical compounds
|
|
GB0114004D0
(en)
|
2001-06-08 |
2001-08-01 |
Glaxo Group Ltd |
Chemical compounds
|
|
EP1288713A1
(en)
*
|
2001-08-29 |
2003-03-05 |
Chugai Photo Chemical Co. Ltd. |
Processing agent for silver halide color photosensitive material and processing method thereof
|
|
MXPA04003170A
(es)
|
2001-10-03 |
2004-07-08 |
Pharmacia Corp |
Compuestos policiclicos, sustituidos, provisto de 5 miembros, utiles para la inhibicion selectiva de la cascada de coagulacion.
|
|
BR0213092A
(pt)
|
2001-10-03 |
2004-10-19 |
Pharmacia Corp |
Compostos heterocìclicos de 6 elementos úteis para a inibição seletiva da cascata de coagulação
|
|
US7122559B2
(en)
*
|
2003-02-11 |
2006-10-17 |
Bristol-Myers Squibb Company |
Phenylglycine derivatives useful as serine protease inhibitors
|
|
US7144895B2
(en)
*
|
2003-02-11 |
2006-12-05 |
Bristol-Myers Squibb Co. |
Benzene acetamide compounds useful as serine protease inhibitors
|
|
MXPA05013365A
(es)
*
|
2003-06-20 |
2006-04-05 |
Arena Pharm Inc |
Derivados de n-fenil-piperazina y metodos para profilaxis o tratamiento de enfermedades asociadas con el receptor 5ht2c.
|
|
US7202363B2
(en)
|
2003-07-24 |
2007-04-10 |
Abbott Laboratories |
Thienopyridine and furopyridine kinase inhibitors
|
|
TW200633721A
(en)
*
|
2004-12-14 |
2006-10-01 |
Shionogi & Co |
A pharmaceutical composition for treating constipation
|
|
EP1838706A1
(en)
|
2004-12-24 |
2007-10-03 |
Prosidion Limited |
G-protein coupled receptor agonists
|
|
AR054321A1
(es)
*
|
2005-01-10 |
2007-06-20 |
Bristol Myers Squibb Co |
Derivados en fenilglicinamida utiles como anticoagulantes
|
|
GB0507577D0
(en)
|
2005-04-14 |
2005-05-18 |
Novartis Ag |
Organic compounds
|
|
DE602006011752D1
(de)
*
|
2005-06-24 |
2010-03-04 |
Bristol Myers Squibb Co |
Als antikoagulationsmittel geeignete phenylglycinamid- und pyridylglycinamidderivate
|
|
TWI389899B
(zh)
*
|
2006-08-08 |
2013-03-21 |
Msd Oss Bv |
具口服活性之凝血酶抑制劑
|
|
CL2007002920A1
(es)
*
|
2006-10-13 |
2008-06-06 |
Actelion Pharmaceuticals Ltd |
Compuestos derivados de 2-aminocarbonilpiridina; composicion farmaceutica; y uso para el tratamiento de trastornos vasculares oclusivos.
|
|
EP2123644B1
(en)
|
2007-03-07 |
2014-12-17 |
Takeda Pharmaceutical Company Limited |
Benzoxazepine derivatives and use thereof
|
|
WO2008144483A2
(en)
*
|
2007-05-18 |
2008-11-27 |
Armgo Pharma, Inc. |
Agents for treating disorders involving modulation of ryanodine receptors
|
|
EP2138494A1
(en)
|
2008-06-26 |
2009-12-30 |
Sanofi-Aventis |
Substituted alkyl pyrimidin-4-one derivatives
|
|
EP2138493A1
(en)
|
2008-06-26 |
2009-12-30 |
Sanofi-Aventis |
Substituted pyrimidone derivatives
|
|
EP2138492A1
(en)
|
2008-06-26 |
2009-12-30 |
Sanofi-Aventis |
Substituted pyrimidin-4-one derivatives
|
|
EP2138488A1
(en)
|
2008-06-26 |
2009-12-30 |
sanofi-aventis |
4-(pyridin-4-yl)-1H-[1,3,5]triazin-2-one derivatives as GSK3-beta inhibitors for the treatment of neurodegenerative diseases
|
|
EP2138498A1
(en)
|
2008-06-26 |
2009-12-30 |
sanofi-aventis |
Substituted tricyclic derivatives against neurodegenerative diseases
|
|
EP2138485A1
(en)
|
2008-06-26 |
2009-12-30 |
sanofi-aventis |
Substituted N-Oxide pyrazine derivatives
|
|
EP2138495A1
(en)
|
2008-06-26 |
2009-12-30 |
sanofi-aventis |
Substituted pyrimido[2,1-a]isoquinolin-4-one derivatives
|
|
CN101684077B
(zh)
|
2008-09-24 |
2013-01-02 |
浙江九洲药业股份有限公司 |
N-酰基联苯丙氨酸的制备方法
|
|
CN101774941A
(zh)
*
|
2009-01-13 |
2010-07-14 |
浙江九洲药业股份有限公司 |
2-酰基氨基-3-联苯基丙酸的制备及拆分方法
|
|
CN101555211B
(zh)
*
|
2009-05-13 |
2012-01-25 |
浙江九洲药业股份有限公司 |
2-酰基氨基-3-联苯基丙酸的化学合成方法
|
|
BR112012006406A2
(pt)
*
|
2009-09-23 |
2016-04-12 |
Novartis Ag |
"processo para a fabrição de n-acilbifenil alanina"
|
|
WO2012015949A2
(en)
*
|
2010-07-29 |
2012-02-02 |
Joule Unlimited Technologies, Inc. |
Methods and compositions for improving yields of reduced products of photosynthetic microorganisms
|
|
CN103201279A
(zh)
|
2010-11-05 |
2013-07-10 |
赛诺米克斯公司 |
作为trpm8的调节剂有用的化合物
|
|
EP2606893A1
(en)
|
2011-12-21 |
2013-06-26 |
Sanofi |
Sulphonylaminopyrrolidinone derivatives, their preparation and their therapeutic application
|
|
RU2712621C2
(ru)
|
2013-05-23 |
2020-01-30 |
Калвиста Фармасьютикалз Лимитед |
Азотсодержащие гетероциклические производные, полезные в качестве ингибитора калликреина плазмы
|
|
ITUB20150417A1
(it)
*
|
2015-05-08 |
2016-11-08 |
Dipharma Francis Srl |
Procedimento per la preparazione di composti piperidinici
|
|
BR112018006471B1
(pt)
|
2015-10-01 |
2024-02-27 |
Senomyx, Inc |
Composto, composição, método de modular o membro de melastina do canal potencial do receptor transitório 8 (trpm8), método de modular a sensação de resfrescância de uma composição e método de induzir uma sensação de refrescância em um ser humano ou animal
|
|
GB201805174D0
(en)
*
|
2018-03-29 |
2018-05-16 |
Univ Leeds Innovations Ltd |
Compounds
|
|
GB201807014D0
(en)
*
|
2018-04-30 |
2018-06-13 |
Univ Leeds Innovations Ltd |
Factor xlla inhibitors
|
|
DK3993876T3
(en)
|
2019-07-01 |
2024-12-02 |
Tonix Pharma Ltd |
Anti-cd154 antibodies and uses thereof
|
|
WO2021032933A1
(en)
*
|
2019-08-21 |
2021-02-25 |
Kalvista Pharmaceuticals Limited |
Enzyme inhibitors
|
|
EP4017850A1
(en)
*
|
2019-08-21 |
2022-06-29 |
Kalvista Pharmaceuticals Limited |
Enzyme inhibitors
|
|
AR121715A1
(es)
*
|
2020-04-03 |
2022-06-29 |
Biocryst Pharm Inc |
Pirrolopirimidinaminas como inhibidores del sistema del complemento
|
|
AU2022205313A1
(en)
|
2021-01-06 |
2023-07-20 |
Tonix Pharma Limited |
Methods of inducing immune tolerance with modified anti-cd154 antibodies
|
|
WO2024044098A2
(en)
*
|
2022-08-23 |
2024-02-29 |
Alexion Pharmaceuticals, Inc. |
Pharmaceutical compounds for the treatment of complement mediated disorders
|
|
WO2025248134A1
(en)
|
2024-05-31 |
2025-12-04 |
Tonix Pharma Limited |
Treatment methods comprising administration of modified cd154 antibodies
|
|
CN119954681B
(zh)
*
|
2025-02-05 |
2025-12-26 |
南京工业大学 |
一种小分子光交联剂、制备方法及应用
|